Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 1
1979 1
1980 1
1982 2
1983 1
1984 1
1985 1
1987 3
1989 2
1990 2
1991 4
1992 4
1993 6
1994 5
1995 5
1996 6
1997 4
1998 8
1999 4
2000 5
2001 4
2002 3
2003 9
2004 4
2005 9
2006 9
2007 10
2008 6
2009 12
2010 9
2011 7
2012 8
2013 12
2014 12
2015 11
2016 10
2017 10
2018 18
2019 11
2020 7
2021 9
2022 13
2023 14
2024 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization.
Onodera T, Wang MY, Rutkowski JM, Deja S, Chen S, Balzer MS, Kim DS, Sun X, An YA, Field BC, Lee C, Matsuo EI, Mizerska M, Sanjana I, Fujiwara N, Kusminski CM, Gordillo R, Gautron L, Marciano DK, Hu MC, Burgess SC, Susztak K, Moe OW, Scherer PE. Onodera T, et al. Nat Commun. 2023 Oct 17;14(1):6531. doi: 10.1038/s41467-023-42188-4. Nat Commun. 2023. PMID: 37848446 Free PMC article.
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.
Moriyama S, Anraku Y, Taminishi S, Adachi Y, Kuroda D, Kita S, Higuchi Y, Kirita Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y. Moriyama S, et al. Among authors: onodera t. Nat Commun. 2023 Jul 14;14(1):4198. doi: 10.1038/s41467-023-39890-8. Nat Commun. 2023. PMID: 37452031 Free PMC article.
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ; ACTIVATE Investigators. Al-Samkari H, et al. Among authors: onodera k. N Engl J Med. 2022 Apr 14;386(15):1432-1442. doi: 10.1056/NEJMoa2116634. N Engl J Med. 2022. PMID: 35417638 Clinical Trial.
High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.
Mitsui J, Matsukawa T, Uemura Y, Kawahara T, Chikada A, Porto KJL, Naruse H, Tanaka M, Ishiura H, Toda T, Kuzuyama H, Hirano M, Wada I, Ga T, Moritoyo T, Takahashi Y, Mizusawa H, Ishikawa K, Yokota T, Kuwabara S, Sawamoto N, Takahashi R, Abe K, Ishihara T, Onodera O, Matsuse D, Yamasaki R, Kira JI, Katsuno M, Hanajima R, Ogata K, Takashima H, Matsushima M, Yabe I, Sasaki H, Tsuji S. Mitsui J, et al. Among authors: onodera o. EClinicalMedicine. 2023 Apr 14;59:101920. doi: 10.1016/j.eclinm.2023.101920. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37256098 Free PMC article.
The ubiquinol group also showed better secondary efficacy outcomes (Barthel index, Scale for the Assessment and Rating of Ataxia, and time required to walk 10 m). Rates of adverse events potentially related to the investigational drug were comparable between ubiquinol (n = …
The ubiquinol group also showed better secondary efficacy outcomes (Barthel index, Scale for the Assessment and Rating of Ataxia, and time r …
Magnetic Resonance Water Tracer Imaging Using 17 O-Labeled Water.
Kameda H, Kinota N, Kato D, Fujii T, Harada T, Komaki Y, Sugimori H, Onodera T, Tomiyasu M, Obata T, Kudo K. Kameda H, et al. Among authors: onodera t. Invest Radiol. 2024 Jan 1;59(1):92-103. doi: 10.1097/RLI.0000000000001021. Epub 2023 Sep 15. Invest Radiol. 2024. PMID: 37707860 Review.
Deep physical neural networks trained with backpropagation.
Wright LG, Onodera T, Stein MM, Wang T, Schachter DT, Hu Z, McMahon PL. Wright LG, et al. Among authors: onodera t. Nature. 2022 Jan;601(7894):549-555. doi: 10.1038/s41586-021-04223-6. Epub 2022 Jan 26. Nature. 2022. PMID: 35082422 Free PMC article.
Radiosensitization to γ-Ray by Functional Inhibition of APOBEC3G.
Tong Y, Kikuhara S, Onodera T, Chen L, Myat AB, Imamichi S, Sasaki Y, Murakami Y, Nozaki T, Fujimori H, Masutani M. Tong Y, et al. Among authors: onodera t. Int J Mol Sci. 2022 May 3;23(9):5069. doi: 10.3390/ijms23095069. Int J Mol Sci. 2022. PMID: 35563460 Free PMC article.
Cell cycle analysis revealed that APOBEC3G knockdown increased S-phase arrest in MIAPaCa2 and G2/M arrest in A549 cells after gamma-irradiation. DNA double-strand break marker gammaH2AX level was increased in APOBEC3G-knocked-down MIAPaCa2 cells after gamma-irradiation. .. …
Cell cycle analysis revealed that APOBEC3G knockdown increased S-phase arrest in MIAPaCa2 and G2/M arrest in A549 cells after gamma-i …
Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin.
Onodera R, Motoyama K, Tanaka N, Ohyama A, Okamatsu A, Higashi T, Kariya R, Okada S, Arima H. Onodera R, et al. Sci Rep. 2014 Mar 20;4:4417. doi: 10.1038/srep04417. Sci Rep. 2014. PMID: 24646866 Free PMC article.
Most recently, we newly synthesized folate-appended methyl-beta-cyclodextrin (FA-M-beta-CyD), and demonstrated the potential of FA-M-beta-CyD as a new antitumor drug. ...In contrast to methyl-beta-cyclodextrin (M-beta-CyD), FA-M-beta-CyD entered KB cel …
Most recently, we newly synthesized folate-appended methyl-beta-cyclodextrin (FA-M-beta-CyD), and demonstrated the potential of FA- …
Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
Motoyama K, Onodera R, Tanaka N, Kameyama K, Higashi T, Kariya R, Okada S, Arima H. Motoyama K, et al. Among authors: onodera r. Biol Pharm Bull. 2015;38(3):374-9. doi: 10.1248/bpb.b14-00531. Biol Pharm Bull. 2015. PMID: 25757918 Free article.
FA-M-beta-CyD showed cytotoxic effects in Ihara cells, a human melanoma cell line expressing FR-alpha. ...Additionally, FA-M-beta-CyD elicited the formation of autophagosomes in Ihara cells. Notably, FA-M-beta-CyD suppressed melanoma growth in BALB/c nude rec …
FA-M-beta-CyD showed cytotoxic effects in Ihara cells, a human melanoma cell line expressing FR-alpha. ...Additionally, FA-M-b …
275 results